Category: Immune monitoring

F.40 - Production and Use of External Standards for Antigen-specific T-cell Assays

Friday, Jun 16
6:15 PM – 7:30 PM

Sebastian Attig

TRON Mainz (Germany)
Mainz, Rheinland-Pfalz, Germany

Nicole Bidmon

Biontech, Mainz (Germany)
Mainz, Rheinland-Pfalz, Germany

Cedrik Britten

TRON Mainz (Germany)/GSK Stevenage (UK)* (*current affiliation)
Mainz, Rheinland-Pfalz, Germany

Maren Eckey

JPT Peptide Technologies, Berlin (Germany)
Berlin, Berlin, Germany

Cecile Gouttefangeas

University of Tübingen (Germany)
Tübingen, Baden-Wurttemberg, Germany

Pavlo Holenya

JPT Peptide Technologies, Berlin (Germany)
Berlin, Berlin, Germany

Florian Kern

JPT Peptide Technologies, Berlin (Germany) /Brighton and Sussex Medical School (UK)
Brighton, England, United Kingdom

Tana Omokoko

Biontech, Mainz (Germany)
Mainz, Rheinland-Pfalz, Germany

Richard Rae

TRON Mainz (Germany)
Mainz, Rheinland-Pfalz, Germany

Ulf Reimer

JPT Peptide Technologies, Berlin (Germany)
Berlin, Berlin, Germany

Ugur Sahin

CEO
Biontech, Mainz (Germany)
Mainz, Rheinland-Pfalz, Germany

Marij Schoenemakers-Welters

Leiden University Medical Centre (Netherlands)
Leiden, Zuid-Holland, Netherlands

Petra Simon

Biontech, Mainz (Germany)
Mainz, Rheinland-Pfalz, Germany

Sjoerd Van der Burg

Leiden University Medical Centre (Netherlands)
Leiden, Zuid-Holland, Netherlands

Holger Wenschuh

CEO
JPT Peptide Technologies, Berlin (Germany)
Berlin, Berlin, Germany

Aaron Castro

Theracode JPT Inc. (US)
Acton, Massachusetts